Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

LSUHSC research shows drug blocks enzyme that activates bacterial and viral toxins

18.11.2002


A paper published in the December, 2002 issue of Infection and Immunity by a research team at the Louisiana State University (LSU) Health Sciences Center in New Orleans provides clear evidence that the lethal toxins of such infectious bacteria as Pseudomonas and anthrax can be blocked by a drug developed at the LSU Health Sciences Center in New Orleans. The compound, called D6R (hexa-D-arginine), is a potent, stable, small molecule inhibitor of furin.



Bacteria produce a number of toxins which rapidly enter and kill cells. In anthrax, the lethal factor toxin must bind to another part of the anthrax toxin, called the PA molecule, before it can enter and destroy a cell. But before binding can occur, the PA molecule produced by the bacteria must be made smaller. Furin, a protein-cutting enzyme or protease, which sits on the outside of cells, cuts the PA molecule, making it small enough for the lethal factor toxin to attach. Lethal factor toxin cannot bind to PA that has not already been cut by furin; therefore, without cut PA, lethal factor toxin loses the ability to bind to and enter the cell, and becomes harmless.

Working on the theory that if the action of furin could be blocked, the toxins would not be activated and therefore unable to kill cells, the research team set out to make a peptide that would suppress furin activity. In collaboration with a research group in California (Torrey Pines Institute for Molecular Studies), the LSUHSC group developed the furin inhibitor, D6R, for which a patent application has now been filed. The LSUHSC research group under the direction of Dr. Iris Lindberg, Professor of Biochemistry, included current postdoctoral fellow Dr. Miroslav S. Sarac, and past fellow Dr. Angus Cameron.


In the current paper, the LSUHSC research scientists examined the therapeutic potential of D6R against Pseudomonas aeruginosa exotoxin, both in cell culture and in live animals (mice). Various concentrations of D6R were tested, with no apparent side effects, regardless of dose. (However, no tissue microhistology has yet been done, and these studies are needed to reveal any subtle damaging effects.) The survival rate of cells in culture 48 hours after treatment with D6R–given at the same time as Pseudomonas toxin-- was significant–50%. The survival rate of the group of mice treated with D6R for two days prior to administration of toxin was also about 50% at seven days. The group of mice treated with D6R at the same time toxin was administered showed a 25% survival rate.

Pseudomonas aeruginosa is an opportunistic pathogen causing urinary tract infections, respiratory system infections, dermatitis, soft tissue infections, bacteremia and a variety of systemic infections, especially in those with immunosuppression related to cancer, HIV and severe burns. P. aeruginosa is known for its resistance to antibiotics. Although some antibiotics are effective against some strains, even those antibiotics are not effective against all strains.

Sepsis, a systemic infection, is the leading cause of death among critically ill patients in the US. It is estimated that about 750,000 American people develop sepsis each year and that more than 200,000 die from it. One of the factors contributing to the high mortality of sepsis (which has increased more than 90% in the last 20 years according to the National Vital Statistics Report, 2000,) is damage from excessive production of cytokines (chemical messengers of the immune system). The LSUHSC scientists found that D6R was not only able to protect cells from lethal toxins, but to do so without invoking a cytokine response itself. D6R also dramatically lowered the production of one cytokine, TNF.

According to the researchers, D6R appears to exhibit a number of potentially promising attributes. It is able to cross cell membranes; it is small enough to achieve useful therapeutic concentrations; and it exhibits no apparent toxicity at concentrations 100x therapeutic levels. It could also prove useful in treating infection from other viruses and bacteria whose toxins are dependent upon furin activity for activation. Besides Pseudomonas and anthrax, these include Ebola, clostridium, diphtheria, shiga, RSV, HIV-1, infectious bronchitis and yellow fever among others.

Dr. Lindberg was recently awarded a grant by the National Institute of Allergy and Infectious Diseases to test D6R against anthrax toxin in both cells as well as animal models (rats and mice). She will further examine the structural requirements of D6R-related molecules against furin with the idea of eventually using D6R (or a better drug developed through these studies) as a therapeutic drug for anthrax, Pseudomonas and other furin-dependent infections. She will also conduct safety and toxicity studies during the grant period.

"This is very exciting research," said Dr. Lindberg. "We hope that D6R-like furin inhibitors will represent effective and potent new drugs that will not only prove a viable approach to combat some types of bacterial infection, but also add to our country’s bioweapons defense arsenal."

Leslie Capo | EurekAlert!
Further information:
http://www.lsumc.edu/

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>